FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+26.21%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$770M
AUM Growth
+$770M
(+23%)
Cap. Flow
-$862K
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
48.86%
Holding
67
New
8
Increased
35
Reduced
18
Closed
4
Top Buys
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$22.9M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$22.5M |
| 3 |
Dynavax Technologies
DVAX
|
$9.97M |
| 4 |
Halozyme
HALO
|
$8.58M |
| 5 |
Takeda Pharmaceutical
TAK
|
$8.42M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$28.4M |
| 2 |
Veracyte
VCYT
|
$18.8M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$15.4M |
| 4 |
NeoGenomics
NEO
|
$12.3M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$11.4M |
Sector Composition
| 1 | Healthcare | 76.57% |
| 2 | Communication Services | 4.96% |
| 3 | Financials | 0.82% |
| 4 | Energy | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $54.2M | 7.04% | 2,221,721 -632,105 | -22% | -$15.4M |
|
2
Ionis Pharmaceuticals
IONS
$6.79B
| $49.6M | 6.45% | 611,162 +21,152 | +4% | +$1.72M |
|
|
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $47.3M | 6.14% | 2,743,479 +228,927 | +9% | +$3.94M |
|
4
Omnicell
OMCL
$1.5B
| $42.2M | 5.48% | 522,049 -138,606 | -21% | -$11.2M |
|
|
MODN
5
DELISTED
MODEL N, INC.
MODN
| $38.2M | 4.96% | 2,175,594 +449,190 | +26% | +$7.88M |
|
|
6
NeoGenomics
NEO
$1.13B
| $32.8M | 4.27% | 1,604,611 -603,577 | -27% | -$12.3M |
|
7
Harvard Bioscience
HBIO
$22M
| $30.5M | 3.96% | 7,070,238 +60,652 | +0.9% | +$261K |
|
8
Heron Therapeutics
HRTX
$207M
| $27.2M | 3.53% | 1,112,966 +287,697 | +35% | +$7.03M |
|
|
SPNE
9
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $27.1M | 3.53% | 1,800,235 +15,164 | +0.8% | +$229K |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $27M | 3.51% | 1,404,713 +44,433 | +3% | +$854K |
|
11
Nektar Therapeutics
NKTR
$568M
| $25.7M | 3.33% | 763,403 +33,177 | +5% | +$1.11M |
|
12
AtriCure
ATRC
$1.84B
| $24.5M | 3.18% | 914,307 -51,490 | -5% | -$1.38M |
|
|
13
Halozyme
HALO
$8.56B
| $23.7M | 3.08% | 1,471,498 +533,099 | +57% | +$8.58M |
|
|
XENT
14
DELISTED
Intersect ENT, Inc
XENT
| $23.2M | 3.01% | 720,240 +18,842 | +3% | +$606K |
|
|
MYOK
15
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $22.9M | 2.97% | +439,635 | New | +$22.9M |
|
|
AERI
16
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $22.5M | 2.93% | +474,066 | New | +$22.5M |
|
|
17
Veracyte
VCYT
$2.39B
| $19.3M | 2.51% | 772,579 -750,826 | -49% | -$18.8M |
|
18
Tandem Diabetes Care
TNDM
$845M
| $17M | 2.21% | 267,954 +4,071 | +2% | +$259K |
|
19
Ligand Pharmaceuticals
LGND
$3.15B
| $16.5M | 2.15% | 131,559 +37,177 | +39% | +$4.67M |
|
20
Xencor
XNCR
$580M
| $15.9M | 2.06% | 511,328 +45,558 | +10% | +$1.42M |
|
21
Codexis
CDXS
$246M
| $14.9M | 1.93% | 723,760 -335,599 | -32% | -$6.89M |
|
|
NVTR
22
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $14.7M | 1.91% | 1,338,067 +175,616 | +15% | +$1.93M |
|
|
KDNY
23
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $14.4M | 1.87% | 3,611,668 +42,713 | +1% | +$170K |
|
|
24
Dynavax Technologies
DVAX
$1.19B
| $12.5M | 1.62% | 1,709,541 +1,364,202 | +395% | +$9.97M |
|
25
KORU Medical Systems
KRMD
$195M
| $11M | 1.43% | 6,884,200 +35,300 | +0.5% | +$56.5K |
|